Chronic Heart Failure: New Therapeutic Options for Improving Patient Outcomes

Steering Committee Biographies

All steering committee and speaking faculty disclosures will be provided onsite in program syllabi distributed to all grand rounds participants.

Gregg C. Fonarow, MD, FACC, FAHAGregg C. Fonarow, MD, FACC, FAHA

Eliot Corday Professor in Cardiovascular Medicine and Science
Director, Ahmanson‐UCLA Cardiomyopathy Center
Co‐chief of Clinical Cardiology, UCLA Division of Cardiology
Co‐director, UCLA Preventative Cardiology Program
David Geffen School of Medicine
Los Angeles, CA

Gregg C. Fonarow, MD, FACC, FAHA is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA. He serves as Director of the Ahmanson-UCLA Cardiomyopathy Center, Co-Director of UCLA's Preventative Cardiology Program, and Clinical Co-Chief of Cardiology in the UCLA Division of Cardiology. He attained the rank of Professor of Medicine, Geffen School of Medicine, at UCLA in 2003.

His research interests center on acute and chronic heart failure, preventive cardiology, quality of care, outcomes, and implementing treatment systems to improve clinical outcomes. Dr. Fonarow has published more than 400 research studies and clinical trials in heart failure, disease management, preventive cardiology, and outcomes research. New therapies and management strategies for advanced heart failure and research into its pathophysiology are studied and implemented at UCLA under his direction. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP), which served as the model for the American Heart Association’s Get with the Guidelines program.

Dr. Fonarow is the immediate past Chair of that program and also chaired OPTIMIZE-HF. He is Co-chair of IMPROVE-HF, a national cardiology practice-based registry and performance-improvement program to improve the use of evidence-based medication and device therapies for heart failure. He is also Chair of the steering committee for the ACC ACTION-GWTG Registry. He is on the steering committee and serves as an investigator for a number of ongoing randomized clinical trials in heart failure. He serves as a reviewer and serves on the editorial boards for a number of leading cardiovascular journals.

James E. Udelson, MDJames E. Udelson, MD

Chief, Division of Cardiology
Tufts Medical Center
Professor of Medicine and Radiology
Tufts University School of Medicine
Boston, MA

James E. Udelson, MD is Chief of the Division of Cardiology and Director of Nuclear Cardiology at Tufts Medical Center. He is a Professor of Medicine and Radiology at Tufts University School of Medicine in Boston, and in 2012 received the Distinguished Faculty Award from the medical school. Dr. Udelson’s research interests involve studying the effects of new therapeutic modalities in the settings of heart failure and chronic coronary artery disease, as well as the development of imaging modalities to assess those effects.

He was Associate Editor for the American Heart Association (AHA) journal Circulation from 2004-2016. In 2008, he was appointed as the initial Editor-in-Chief for the AHA’s new journal, Circulation: Heart Failure. He is on the editorial board and has served as a guest Editor for the Journal of the American College of Cardiology and the Journal of Nuclear Cardiology.

Dr. Udelson has served on the AHA/American College of Cardiology (ACC)/American Society of Nuclear Cardiology (ASNC) Radionuclide Imaging Guidelines writing Task Force, as well as numerous other national Guideline and Appropriate Use Criteria writing groups, including as a Co-chair of the ACC/ACR Writing Committee for Appropriate Use Criteria to Assess Imaging Modalities to Evaluate Chest Pain in the Emergency Department. He is a chapter author for Braunwald’s Heart Disease textbook for the past 3 editions, as well as for the upcoming 2013 11th edition. This is the most widely read textbook of cardiology in the world.

Dr. Udelson is Past President of the American Society of Nuclear Cardiology, and has served a 5-year term on the Board of Trustees of the ACC. He has chaired the ACC’s Cardiovascular Imaging Committee, served on the ACC Publications Committee, and completed a term as Chair of the ACC Governance Committee. He also recently completed a term as a member of the Executive Council of the Heart Failure Society of America.